Search Results - Ruth O’Regan

Refine Results
  1. 1
    The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers

    The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers by Elisavet Paplomata, Ruth O’Regan

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy

    The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy by Zahi Mitri, Tina Constantine, Ruth O’Regan

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics

    The emerging role of mediator complex subunit 12 in tumorigenesis and response to chemotherapeutics by Shengjie Zhang, Ruth O’Regan, Wei Xu

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging

    Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging by Maksym Yezhelyev, Lifeng Qi, Ruth O’Regan, Shuming Nie, Xiaohu Gao

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

    Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance by Sylvia S. Gayle, Samuel L.M. Arnold, Ruth O’Regan, Rita Nahta

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Triple-negative breast cancer in African-American women: disparities versus biology

    Triple-negative breast cancer in African-American women: disparities versus biology by Eric C. Dietze, Christopher Sistrunk, Gustavo A. Miranda‐Carboni, Ruth O’Regan, Victoria L. Seewaldt

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER−/HER2+ Breast Cancer

    ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER−/HER2+ Breast Cancer by Cletus Arciero, Yi Guo, Renjian Jiang, Madhusmita Behera, Ruth O’Regan, Limin Peng, Xiaoxian Li

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Brain metastases: An update on the multi-disciplinary approach of clinical management

    Brain metastases: An update on the multi-disciplinary approach of clinical management by D.K. Mitchell, Jae Hyun Kwon, P Kubica, Wei Huff, Ruth O’Regan, Mahua Dey

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Effects of Raloxifene After Tamoxifen on Breast and Endometrial Tumor Growth in Athymic Mice

    Effects of Raloxifene After Tamoxifen on Breast and Endometrial Tumor Growth in Athymic Mice by Ruth O’Regan, Csaba Gajdos, R. C. Dardes, A. De Los Reyes, Wonse Park, Alfred Rademaker, V. Craig Jordan

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor

    Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Fac... by Neeraj K. Saxena, LaTonia Taliaferro-Smith, Brandi B. Knight, Didier Merlin, Frank A. Anania, Ruth O’Regan, Dipali Sharma

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer

    Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer by Deli Liu, Huan Xiong, Angela E. Ellis, Nicole C. Northrup, Carlos O. Rodriguez, Ruth O’Regan, Stephen Dalton, Shaying Zhao

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer

    Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer by Niraj Neupane, Sawyer Bawek, Sayuri Gurusinghe, Elham Moases Ghaffary, Omid Mirmosayyeb, Sangharsha Thapa, Carla I. Falkson, Ruth O‘Regan, Ajay Dhakal

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma

    Targeted Glycoproteomic Identification of Biomarkers for Human Breast Carcinoma by Karen L. Abbott, Kazuhiro Aoki, Jae‐Min Lim, Mindy Porterfield, Rachelle W. Johnson, Ruth O’Regan, Lance Wells, Michael Tiemeyer, Michael Pierce

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma

    Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma by Peng Zhao, Alison V. Nairn, Shanterian Hester, Kelley W. Moremen, Ruth O’Regan, Gabriella Oprea, Lance Wells, Michael Pierce, Karen L. Abbott

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab

    Phase I Study of Everolimus Plus Weekly Paclitaxel and Trastuzumab in Patients With Metastatic Breast Cancer Pretreated With Trastuzumab by Fabrice André, Mario Campone, Ruth O’Regan, C. Manlius, Cristian Massacesi, Sahmoud Tarek, Pabak Mukhopadhyay, Jean‐Charles Soria, Michael Naughton, Sara A. Hurvitz

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells

    Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells by Tisheeka Graham, Rami Yacoub, LaTonia Taliaferro‐Smith, Adeboye O. Osunkoya, Valerie Odero-Marah, Tongrui Liu, K. Sean Kimbro, Dipali Sharma, Ruth O’Regan

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    21‐Gene recurrence scores

    21‐Gene recurrence scores by Mary Jo Lund, Marina Mošunjac, Kelly M. Davis, Sheryl Gabram‐Mendola, Monica Rizzo, Harvey L. Bumpers, Sherita Hearn, Amelia Zelnak, Toncred M. Styblo, Ruth O’Regan

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells

    Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells by Tongrui Liu, Rami Yacoub, LaTonia Taliaferro‐Smith, Shi‐Yong Sun, Tisheeka Graham, Ryan S. Dolan, Christine Lobo, Mourad Tighiouart, Lily Yang, Amy L. Adams, Ruth O’Regan

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes

    Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes by Mary Jo Lund, Eboneé N. Butler, Brionna Y. Hair, Kevin C. Ward, J. Andrews, Gabriella Oprea‐Ilies, A. Rana Bayakly, Ruth O’Regan, Paula M. Vertino, J. William Eley

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer

    Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer by Jasmine M. Miller‐Kleinhenz, Xiangxue Guo, Weiping Qian, Hongyu Zhou, Erica N. Bozeman, Lei Zhu, Xin Ji, Y.Andrew Wang, Toncred M. Styblo, Ruth O’Regan, Hui Mao, Lily Yang

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: